CoSyne Therapeutics
CoSyne Therapeutics is a science-first company focused on precision medicine for brain diseases, employing a vertically integrated approach powered by "Polymathic AI." This approach combines hyperscale proprietary data, custom-built biology, and chemistry foundation models to digitize cellular responses to perturbation. By representing biology at higher levels of abstraction, CoSyne trains models that understand multiple layers of systems biology and chemistry. This enables the rapid discovery of drugs targeting specific molecular features of a patient's disease, with the vision of transforming precision medicine into personalized medicine. The company is backed by investors with expertise in technology and life sciences and is based in London and Cambridge.
CoSyne Therapeutics
CoSyne Therapeutics is a science-first company focused on precision medicine for brain diseases, employing a vertically integrated approach powered by "Polymathic AI." This approach combines hyperscale proprietary data, custom-built biology, and chemistry foundation models to digitize cellular responses to perturbation. By representing biology at higher levels of abstraction, CoSyne trains models that understand multiple layers of systems biology and chemistry. This enables the rapid discovery of drugs targeting specific molecular features of a patient's disease, with the vision of transforming precision medicine into personalized medicine. The company is backed by investors with expertise in technology and life sciences and is based in London and Cambridge.